Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HER2 as a prognostic factor in breast cancer.

Oncology - 1 Jan 2001

Ménard S, Fortis S, Castiglioni F, Agresti R, Balsari A

Abstract excerpt

HER2 amplification/overexpression is a marker of poor prognosis in breast cancer. The prognostic impact of HER2 positivity is lower in node-negative compared with node-positive women. The only significant, independent prognostic factors in breast cancer are node status, HER2 status and menopausal status. HER2-positive tumors also contain p53 abnormalities, tend to be hormone receptor and bcl-2 negative, have...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Ductal, Breast
Share to Carcinoma, Intraductal, Noninfiltrating
Share to Diagnostic Tests, Routine

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genes, bcl-2

Share to Genes, erbB-2

Share to Mitotic Index

Share to Necrosis

Share to Neoplasms, Hormone-Dependent

Source

Identifiers

PMID: 11694790
DOI: 10.1159/000055404

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HER2 as a prognostic factor in breast cancer.PMID 11694790Read ↗

The Distinctive Nature of HER2-Positive Breast CancersSemantic proximity Read ↗

The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis.Semantic proximity Read ↗

Role of HER2/neu in tumor progression and therapy.Semantic proximity Read ↗

Key Genes and Prognostic Analysis in HER2+ Breast CancerSemantic proximity Read ↗

Issues and updates: evaluating estrogen receptor-alpha, progesterone receptor, and HER2 in breast cancer.Semantic proximity Read ↗

The Role of ERBB2/HER2 Tyrosine Kinase Receptor in the Regulation of Cell DeathSemantic proximity Read ↗

Imaging features of HER2 overexpression in breast cancer: a systematic review and meta-analysis.Semantic proximity Read ↗

The prognostic significance of wild-type isocitrate dehydrogenase 2 (IDH2) in breast cancerSemantic proximity Read ↗

Breast cancer molecular class ERBB2: preponderance of tumors with apocrine differentiation and expression of basal phenotype markers CK5, CK5/6, and EGFR.Semantic proximity Read ↗

Clinicopathologic analysis of bcl-2 immunostaining in breast carcinoma.Semantic proximity Read ↗

The role of trastuzumab in early stage breast cancer: current data and treatment recommendations.Semantic proximity Read ↗

Immunohistochemical COX-2 overexpression correlates with HER-2/neu overexpression in invasive breast carcinomas: a pilot study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.